SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus

被引:70
作者
Imoto, I
Pimkhaokham, A
Fukuda, Y
Yang, ZQ
Shimada, Y
Nomura, N
Hirai, H
Imamura, M
Inazawa, J
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Div Genet,Bunkyo Ku, Tokyo 1138510, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
[3] Kazusa DNA Res Inst, Facil RI Expt, Kisarazu, Japan
[4] Univ Tokyo, Fac Med, Dept Hematol & Oncol, Tokyo 113, Japan
关键词
amplification; 3q26; SNO; EVI1; PIK3CA; TERC; esophageal squamous cell carcinoma;
D O I
10.1006/bbrc.2001.5428
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amplification of the 3q26 region appears to occur frequently among esophageal squamous cell carcinomas (ESCs). We examined ESC cell lines for amplification and expression levels of four genes in this region: SNO and EVI1, which encode proteins antagonizing transforming growth factor-beta signaling, and two other putative target genes, TERC and PIK3CA Amplification of SNO was accompanied by significant increases in its expression level, suggesting that this gene is activated in an amplification-dependent manner. SNO was also amplified in 5 of 44 primary ESCs (11.4%). However, expression levels of EVI1, TERC, and PIK3CA did not correlate with their copy-numbers, even though EVI1 and TERC showed the same amplification pattern as SNO. Taken together, the data suggest that of the four candidates, SNO is the most probable target in the 3q26 amplicon for involvement in the progression of ESC. (C) 2001 Academic Press.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 48 条
[11]   PHYSICAL ORDERING OF 3 POLYMORPHIC DNA MARKERS SPANNING THE REGIONS CONTAINING A TUMOR SUPPRESSOR GENE OF RENAL-CELL CARCINOMA BY 3-COLOR FLUORESCENT INSITU HYBRIDIZATION [J].
INAZAWA, J ;
ARIYAMA, T ;
ABE, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (12) :1248-1252
[12]  
JIANG W, 1992, CANCER RES, V52, P2980
[13]   The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3 [J].
Kurokawa, M ;
Mitani, K ;
Irie, K ;
Matsuyama, T ;
Takahashi, T ;
Chiba, S ;
Yazaki, Y ;
Matsumoto, K ;
Hirai, H .
NATURE, 1998, 394 (6688) :92-96
[14]   The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-β-mediated growth inhibition of myeloid cells [J].
Kurokawa, M ;
Mitani, K ;
Imai, Y ;
Ogawa, S ;
Yazaki, Y ;
Hirai, H .
BLOOD, 1998, 92 (11) :4003-4012
[15]  
LEVY ER, 1994, BLOOD, V83, P1348
[16]   AMPLIFICATION OF THE EGF RECEPTOR AND C-MYC GENES IN HUMAN ESOPHAGEAL CANCERS [J].
LU, SH ;
HSIEH, LL ;
LUO, FC ;
WEINSTEIN, IB .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :502-505
[17]   PIK3CA as an oncogene in cervical cancer [J].
Ma, YY ;
Wei, SJ ;
Lin, YC ;
Lung, JC ;
Chang, TC ;
Whang-Peng, J ;
Liu, JM ;
Yang, DM ;
Yang, WK ;
Shen, CY .
ONCOGENE, 2000, 19 (23) :2739-2744
[18]   INACTIVATION OF THE TYPE-II TGF-BETA RECEPTOR IN COLON-CANCER CELLS WITH MICROSATELLITE INSTABILITY [J].
MARKOWITZ, S ;
WANG, J ;
MYEROFF, L ;
PARSONS, R ;
SUN, LZ ;
LUTTERBAUGH, J ;
FAN, RS ;
ZBOROWSKA, E ;
KINZLER, KW ;
VOGELSTEIN, B ;
BRATTAIN, M ;
WILLSON, JKV .
SCIENCE, 1995, 268 (5215) :1336-1338
[19]   TGF-β signal transduction [J].
Massagué, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :753-791
[20]   ACTIVATION OF EVI1 GENE-EXPRESSION IN HUMAN ACUTE MYELOGENOUS LEUKEMIAS BY TRANSLOCATIONS SPANNING 300-400 KILOBASES ON CHROMOSOME BAND-3Q26 [J].
MORISHITA, K ;
PARGANAS, E ;
WILLMAN, CL ;
WHITTAKER, MH ;
DRABKIN, H ;
OVAL, J ;
TAETLE, R ;
VALENTINE, MB ;
IHLE, JN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3937-3941